AbbVie (ABBV) Current Deferred Tax Assets (2012 - 2015)

AbbVie has disclosed Current Deferred Tax Assets across 4 years of filings, most recently posting $1.1 billion for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 109.92% year-over-year to $1.1 billion; the TTM figure through Sep 2015 stood at $1.1 billion (up 109.92% YoY), while the FY2014 annual figure was $896.0 million, up 16.97% from the prior year.
• Current Deferred Tax Assets retreated to $1.1 billion in Q3 2015, from $1.2 billion in the prior quarter.
• Over the last five years, Current Deferred Tax Assets for ABBV reached as high as $1.4 billion in Q2 2013 and fell as low as $524.0 million in Q3 2014.
• The 4-year median for Current Deferred Tax Assets is $1.1 billion (2014), against an average of $1.1 billion.
• Annual changes were most pronounced in 2014 — Current Deferred Tax Assets plunged 63.07% — and 2015, when it soared 109.92%.
• A 4-year view of Current Deferred Tax Assets shows it stood at $669.0 million in 2012, then increased by 14.5% to $766.0 million in 2013, then grew by 16.97% to $896.0 million in 2014, then rose by 22.77% to $1.1 billion in 2015.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $1.1 billion, $1.2 billion, and $1.1 billion for Q3 2015, Q2 2015, and Q1 2015 respectively.